Skip to content
Screener

Relay Therapeutics, Inc. RLAY Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Schrodinger logo
SchrodingerSDGR
$100.91M-6.0%
PVL
Palvella TherapeuticsPVLA
$528K
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$40.27M-20.0%
Celcuity logo
CelcuityCELC
$13K-92.4%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$127.84M+12.1%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$6.44M-19.4%

Other financials

Income statement

See full
Revenue$350.0K-48.3%
Operating income-$90.8M-18.2%
Net income-$83.7M-18.9%
EPS (diluted)-$0.410.0%

Balance sheet

See full
Cash & equivalents$121.2M+6.4%
Total debt$30.7M-10.3%
Total equity$890.0M+33.7%
Total assets$967.5M+32.7%

Cash flow

See full
Operating cash flow-$54.1M+2.1%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$4.3B+611%
Enterprise value$4.21B+702%
P/S415.9×+343×

Profitability

See full
Operating margin-2,999.4%-637pp
Net margin-2,763.6%-568pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-36.8%-6.3pp
Debt / equity0.0×
Current ratio18.3×-2.7×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338056
Line itemJune 30, 2026December 31, 2025
Other current assets8,4135,974
Total current assets928,082578,279
Property and equipment, net8621,726
Operating lease assets37,17739,990
Restricted cash1,3361,336
Total assets$967,457$621,331
Liabilities and Stockholders’ Equity
Current liabilities:

Item 1. Financial Statements.

FAQ

What is Relay Therapeutics, Inc.'s operating lease ROU assets?
Relay Therapeutics, Inc. (RLAY) reported operating lease ROU assets of $37.18M in Q2 2026.
How has Relay Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
Relay Therapeutics, Inc.'s operating lease ROU assets decreased by 13.0% year-over-year, from $42.73M to $37.18M.
What is the long-term trend for Relay Therapeutics, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s operating lease ROU assets has grown at a 12.1% compound annual growth rate (CAGR), from $22.58M to $39.99M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Relay Therapeutics, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude